Spots Global Cancer Trial Database for Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
Official Title: Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer: Impact on Risk Estimates, Management Recommendations, Clinical Outcomes, and Patient Perception
Study ID: NCT03688204
Conditions
Interventions
Study Description
Brief Summary: This study aims to assess how a polygenic risk score (PRS) reported with the results of multi-gene panel testing affects the breast cancer risk management recommendations healthcare providers make to their patients. The PRS is a score based on small genetic changes, clinical history, and family history. The PRS is used to estimate remaining lifetime risk of developing breast cancer for patients with no personal history of breast cancer and an overall negative result from MGPT.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Providence Roy and Patricia Disney Family Cancer Center, Burbank, California, United States
St Joseph Hospital of Orange, Orange, California, United States
Edwards Comprehensive Cancer Center, Huntington, West Virginia, United States
Contact Details
Name: Brigette Tippin-Davis, PhD
Affiliation: Ambry Genetics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
